GPCRdb

Ligand source activities (1 row/activity)

Potency
Affinity

Get vendors

Ligands (move mouse cursor over ligand name to see structure)					Receptor			Assay information							Chemical information
Sel. page	Common name	GPCRdb ID	#Vendors	Reference ligand	Fold selectivity	# Tested GPCRs	Species	p-value (-log)	Activity Type	Activity Relation	Activity Value	AssayType	Assay Description	Source	Mol weight	Rot Bonds	H don	H acc	LogP	Smiles	DOI
	122195891	124197	0	None	-269	2	Human	6.0	pEC50	=	6	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	489	7	6	13	-0.1	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1	10.1021/acs.jmedchem.5b00575
	CHEMBL3634182	124197	0	None	-269	2	Human	6.0	pEC50	=	6	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	489	7	6	13	-0.1	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1	10.1021/acs.jmedchem.5b00575
	122195895	124201	0	None	-11	2	Human	6.0	pEC50	=	6	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	477	6	6	12	-0.2	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)S)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL3634186	124201	0	None	-11	2	Human	6.0	pEC50	=	6	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	477	6	6	12	-0.2	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)S)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	73351984	90381	0	None	-1	2	Human	6.0	pEC50	=	6	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	457	6	5	12	-1.5	B[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)O	10.1021/jm400197m
	CHEMBL2386492	90381	0	None	-1	2	Human	6.0	pEC50	=	6	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	457	6	5	12	-1.5	B[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)O	10.1021/jm400197m
	122195893	124199	0	None	-3	2	Human	6.0	pEC50	=	6.0	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	557	8	7	14	-0.0	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL3634184	124199	0	None	-3	2	Human	6.0	pEC50	=	6.0	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	557	8	7	14	-0.0	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	23656760	14712	0	None	-	1	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	974	9	4	10	10.0	O=S(=O)(O)OC(=C\c1cc(Br)c2oc(-c3ccc(O)c(Br)c3)cc2c1)/C(=C/c1cc(Br)c2oc(-c3ccc(O)c(Br)c3)cc2c1)OS(=O)(=O)O	10.1021/jm070043r
	CHEMBL1206193	14712	0	None	-	1	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	974	9	4	10	10.0	O=S(=O)(O)OC(=C\c1cc(Br)c2oc(-c3ccc(O)c(Br)c3)cc2c1)/C(=C/c1cc(Br)c2oc(-c3ccc(O)c(Br)c3)cc2c1)OS(=O)(=O)O	10.1021/jm070043r
	CHEMBL240681	14712	0	None	-	1	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	974	9	4	10	10.0	O=S(=O)(O)OC(=C\c1cc(Br)c2oc(-c3ccc(O)c(Br)c3)cc2c1)/C(=C/c1cc(Br)c2oc(-c3ccc(O)c(Br)c3)cc2c1)OS(=O)(=O)O	10.1021/jm070043r
	73353445	90385	0	None	7	2	Human	6.9	pEC50	=	6.9	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	603	8	6	13	-0.1	B[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O	10.1021/jm400197m
	CHEMBL2386496	90385	0	None	7	2	Human	6.9	pEC50	=	6.9	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	603	8	6	13	-0.1	B[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O	10.1021/jm400197m
	56941832	76780	0	None	-42	2	Human	4.9	pEC50	=	4.9	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	908	16	10	25	-2.5	BP(=O)(OP(=O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)OP(=O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	10.1021/jm100597c
	CHEMBL1802094	76780	0	None	-42	2	Human	4.9	pEC50	=	4.9	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	908	16	10	25	-2.5	BP(=O)(OP(=O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)OP(=O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	10.1021/jm100597c
	CHEMBL2068734	76780	0	None	-42	2	Human	4.9	pEC50	=	4.9	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	908	16	10	25	-2.5	BP(=O)(OP(=O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)OP(=O)(O)CP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	10.1021/jm100597c
	122195892	124198	0	None	-3	2	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	477	6	6	12	-0.2	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL3634183	124198	0	None	-3	2	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	477	6	6	12	-0.2	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	73347374	90384	0	None	-9	2	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	603	8	6	13	-0.1	B[P@@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O	10.1021/jm400197m
	CHEMBL2386495	90384	0	None	-9	2	Human	5.9	pEC50	=	5.9	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	603	8	6	13	-0.1	B[P@@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O	10.1021/jm400197m
	1756	463	10	None	-38	2	Human	5.8	pEC50	=	5.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	10.1021/jm020046y
	5310954	463	10	None	-38	2	Human	5.8	pEC50	=	5.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	10.1021/jm020046y
	CHEMBL336292	463	10	None	-38	2	Human	5.8	pEC50	=	5.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	10.1021/jm020046y
	73354953	90380	0	None	-	1	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	577	9	5	14	0.8	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H](O)[C@H]3OC(=O)c3ccccc3)c2n1	10.1021/jm400197m
	CHEMBL2386490	90380	0	None	-	1	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	577	9	5	14	0.8	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H](O)[C@H]3OC(=O)c3ccccc3)c2n1	10.1021/jm400197m
	135973538	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	1728	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	2966	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	4261196	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	5361	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	CHEMBL265502	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	DB04786	3710	33	None	-2	10	Human	4.8	pEC50	=	4.8	Functional	The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm020046y
	1712	288	69	None	-41	6	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	427	6	6	12	-1.7	O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	6022	288	69	None	-41	6	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	427	6	6	12	-1.7	O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	CHEMBL14830	288	69	None	-41	6	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	427	6	6	12	-1.7	O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	1712	288	69	None	-41	6	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	427	6	6	12	-1.7	O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	6022	288	69	None	-41	6	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	427	6	6	12	-1.7	O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	CHEMBL14830	288	69	None	-41	6	Human	5.8	pEC50	=	5.8	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	427	6	6	12	-1.7	O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	1713	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	5957	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	91	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	CHEMBL14249	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	DB00171	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	10994891	78429	0	None	-194	4	Human	4.8	pEC50	=	4.8	Functional	Measure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uMMeasure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uM	ChEMBL	517	8	7	13	-1.0	Nc1ncnc2c1ncn2[C@H]1[C@H](O)[C@H](O)[C@]2(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C[C@H]12	10.1021/jm010369e
	CHEMBL2111533	78429	0	None	-194	4	Human	4.8	pEC50	=	4.8	Functional	Measure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uMMeasure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uM	ChEMBL	517	8	7	13	-1.0	Nc1ncnc2c1ncn2[C@H]1[C@H](O)[C@H](O)[C@]2(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C[C@H]12	10.1021/jm010369e
	6083	204815	95	None	-34	7	Human	4.8	pEC50	=	4.8	Functional	Measure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uMMeasure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uM	ChEMBL	347	4	5	10	-1.9	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/jm010369e
	CHEMBL1315633	204815	95	None	-34	7	Human	4.8	pEC50	=	4.8	Functional	Measure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uMMeasure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uM	ChEMBL	347	4	5	10	-1.9	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/jm010369e
	CHEMBL752	204815	95	None	-34	7	Human	4.8	pEC50	=	4.8	Functional	Measure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uMMeasure of Agonist Potency at human P2Y purinoceptor 11 (hP2Y11) stably expressed in 131N1 astrocytoma cell at 10 uM	ChEMBL	347	4	5	10	-1.9	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/jm010369e
	1713	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm010538v
	5957	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm010538v
	91	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm010538v
	CHEMBL14249	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm010538v
	DB00171	520	68	None	-165	10	Human	4.8	pEC50	=	4.8	Functional	Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11Agonist activity by measuring inositol phosphate accumulation in 1321N1 human astrocytoma cells stably expressing human P2Y purinoceptor 11	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm010538v
	CHEMBL2181938	210492	0	None	-3	3	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL		None	None	None		B[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)OP(=O)(O)O	10.1021/jm400197m
	CHEMBL2448332	210492	0	None	-3	3	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL		None	None	None		B[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)OP(=O)(O)O	10.1021/jm400197m
	440317	21748	17	None	2	4	Human	5.5	pEC50	=	5.5	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	523	8	7	14	-1.5	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O	10.1021/jm020046y
	CHEMBL131890	21748	17	None	2	4	Human	5.5	pEC50	=	5.5	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	523	8	7	14	-1.5	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O	10.1021/jm020046y
	1755	289	17	None	-16218	6	Human	4.5	pEC50	=	4.5	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	5310996	289	17	None	-16218	6	Human	4.5	pEC50	=	4.5	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	CHEMBL335206	289	17	None	-16218	6	Human	4.5	pEC50	=	4.5	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm020046y
	122195891	124197	0	None	-269	2	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	489	7	6	13	-0.1	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1	10.1021/acs.jmedchem.5b00575
	CHEMBL3634182	124197	0	None	-269	2	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	489	7	6	13	-0.1	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1	10.1021/acs.jmedchem.5b00575
	1755	289	17	None	-16218	6	Human	4.5	pEC50	=	4.5	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	5310996	289	17	None	-16218	6	Human	4.5	pEC50	=	4.5	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	CHEMBL335206	289	17	None	-16218	6	Human	4.5	pEC50	=	4.5	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	1713	520	68	None	-165	10	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm100597c
	5957	520	68	None	-165	10	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm100597c
	91	520	68	None	-165	10	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm100597c
	CHEMBL14249	520	68	None	-165	10	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm100597c
	DB00171	520	68	None	-165	10	Human	5.5	pEC50	=	5.5	Functional	Agonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysisAgonist activity at GFP tagged-human P2Y11 receptor expressed in human 1321N1 cells assessed as elevation in calcium level after 30 mins by fluorescence spectrophotometric analysis	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm100597c
	118725181	117072	0	None	-524	2	Human	5.4	pEC50	=	5.4	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	457	6	5	12	-1.5	B[P@@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)O	10.1021/jm400197m
	CHEMBL3392138	117072	0	None	-524	2	Human	5.4	pEC50	=	5.4	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	457	6	5	12	-1.5	B[P@@](=O)(OC[C@H]1O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)O	10.1021/jm400197m
	171069	198216	7	None	-60	2	Human	5.4	pEC50	=	5.4	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-0.8	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL575257	198216	7	None	-60	2	Human	5.4	pEC50	=	5.4	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-0.8	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	23656758	14824	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	1018	10	5	11	9.7	O=C(O)c1c(-c2ccc(O)c(Br)c2)oc2c(Br)cc(/C=C(OS(=O)(=O)O)/C(=C/c3cc(Br)c4oc(-c5ccc(O)c(Br)c5)cc4c3)OS(=O)(=O)O)cc12	10.1021/jm070043r
	CHEMBL1207329	14824	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	1018	10	5	11	9.7	O=C(O)c1c(-c2ccc(O)c(Br)c2)oc2c(Br)cc(/C=C(OS(=O)(=O)O)/C(=C/c3cc(Br)c4oc(-c5ccc(O)c(Br)c5)cc4c3)OS(=O)(=O)O)cc12	10.1021/jm070043r
	CHEMBL394381	14824	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	1018	10	5	11	9.7	O=C(O)c1c(-c2ccc(O)c(Br)c2)oc2c(Br)cc(/C=C(OS(=O)(=O)O)/C(=C/c3cc(Br)c4oc(-c5ccc(O)c(Br)c5)cc4c3)OS(=O)(=O)O)cc12	10.1021/jm070043r
	122195892	124198	0	None	-3	2	Human	6.3	pEC50	=	6.3	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	477	6	6	12	-0.2	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL3634183	124198	0	None	-3	2	Human	6.3	pEC50	=	6.3	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	477	6	6	12	-0.2	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	1711	77	15	None	-64565	7	Human	4.3	pEC50	=	4.3	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	553	9	7	15	-0.9	CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10.1021/jm020046y
	5310983	77	15	None	-64565	7	Human	4.3	pEC50	=	4.3	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	553	9	7	15	-0.9	CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10.1021/jm020046y
	CHEMBL336208	77	15	None	-64565	7	Human	4.3	pEC50	=	4.3	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	553	9	7	15	-0.9	CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10.1021/jm020046y
	440317	21748	17	None	2	4	Human	7.2	pEC50	=	7.2	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	523	8	7	14	-1.5	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O	10.1021/jm070043r
	CHEMBL131890	21748	17	None	2	4	Human	7.2	pEC50	=	7.2	Functional	Agonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium levelAgonist activity at P2Y11 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	ChEMBL	523	8	7	14	-1.5	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O	10.1021/jm070043r
	1713	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	5957	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	91	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	CHEMBL14249	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	DB00171	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/acs.jmedchem.5b00575
	1713	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	5957	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	91	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	CHEMBL14249	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	DB00171	520	68	None	-165	10	Human	5.2	pEC50	=	5.2	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	ChEMBL	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10.1021/jm400197m
	44353592	117148	0	None	-	1	Human	5.2	pEC50	=	5.2	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	687	11	6	15	1.9	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1OC(=O)c1ccc(-c2ccccc2)cc1	10.1021/jm020046y
	CHEMBL339386	117148	0	None	-	1	Human	5.2	pEC50	=	5.2	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	687	11	6	15	1.9	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1OC(=O)c1ccc(-c2ccccc2)cc1	10.1021/jm020046y
	171069	198216	7	None	-60	2	Human	5.1	pEC50	=	5.1	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-0.8	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL575257	198216	7	None	-60	2	Human	5.1	pEC50	=	5.1	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	443	6	6	12	-0.8	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	122195894	124200	0	None	-23	2	Human	6.1	pEC50	=	6.1	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	489	7	6	13	-0.1	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)S)[C@@H](O)[C@H]3O)c2n1	10.1021/acs.jmedchem.5b00575
	CHEMBL3634185	124200	0	None	-23	2	Human	6.1	pEC50	=	6.1	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	489	7	6	13	-0.1	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)S)[C@@H](O)[C@H]3O)c2n1	10.1021/acs.jmedchem.5b00575
	14753886	112021	0	None	-	1	Human	6.1	pEC50	=	6.1	Functional	Agonist activity at human P2Y11 receptor expressed in human 1321N1 cells assessed as increase of intracellular calcium level after 30 mins using fura-2 AM by fluorescence assayAgonist activity at human P2Y11 receptor expressed in human 1321N1 cells assessed as increase of intracellular calcium level after 30 mins using fura-2 AM by fluorescence assay	ChEMBL	521	8	7	13	-1.4	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@@](O)(=S)OP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/jm500196c
	CHEMBL3289393	112021	0	None	-	1	Human	6.1	pEC50	=	6.1	Functional	Agonist activity at human P2Y11 receptor expressed in human 1321N1 cells assessed as increase of intracellular calcium level after 30 mins using fura-2 AM by fluorescence assayAgonist activity at human P2Y11 receptor expressed in human 1321N1 cells assessed as increase of intracellular calcium level after 30 mins using fura-2 AM by fluorescence assay	ChEMBL	521	8	7	13	-1.4	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO[P@@](O)(=S)OP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/jm500196c
	15993	1327	51	None	1	2	Human	5.1	pEC50	=	5.1	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10.1021/jm020046y
	1760	1327	51	None	1	2	Human	5.1	pEC50	=	5.1	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10.1021/jm020046y
	CHEMBL335538	1327	51	None	1	2	Human	5.1	pEC50	=	5.1	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10.1021/jm020046y
	DB03222	1327	51	None	1	2	Human	5.1	pEC50	=	5.1	Functional	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	ChEMBL	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10.1021/jm020046y
	122195893	124199	0	None	-3	2	Human	5.0	pEC50	=	5.0	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	557	8	7	14	-0.0	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	CHEMBL3634184	124199	0	None	-3	2	Human	5.0	pEC50	=	5.0	Functional	Agonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assayAgonist activity at GFP-tagged human P2Y11R transfected in human 1321N1 cells assessed as increase in intracellular Ca2+ level by fura 2/AM probe-based fluorescence assay	ChEMBL	557	8	7	14	-0.0	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O	10.1021/acs.jmedchem.5b00575
	1713	520	68	None	-165	10	Human	8.3	pEC50	=	8.3	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	Drug Central	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	None
	5957	520	68	None	-165	10	Human	8.3	pEC50	=	8.3	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	Drug Central	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	None
	91	520	68	None	-165	10	Human	8.3	pEC50	=	8.3	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	Drug Central	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	None
	CHEMBL14249	520	68	None	-165	10	Human	8.3	pEC50	=	8.3	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	Drug Central	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	None
	DB00171	520	68	None	-165	10	Human	8.3	pEC50	=	8.3	Functional	Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assayAgonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay	Drug Central	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	None
	1734	3966	50	None	-1	7	Human	8.3	pEC50	=	8.3	Functional	NoneNone	Drug Central	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	None
	3639	3966	50	None	-1	7	Human	8.3	pEC50	=	8.3	Functional	NoneNone	Drug Central	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	None
	6133	3966	50	None	-1	7	Human	8.3	pEC50	=	8.3	Functional	NoneNone	Drug Central	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	None
	CHEMBL336296	3966	50	None	-1	7	Human	8.3	pEC50	=	8.3	Functional	NoneNone	Drug Central	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	None
	DB04005	3966	50	None	-1	7	Human	8.3	pEC50	=	8.3	Functional	NoneNone	Drug Central	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	None
	1755	289	17	None	-16218	6	Human	4.2	pEC50	=	4.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	5310996	289	17	None	-16218	6	Human	4.2	pEC50	=	4.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	CHEMBL335206	289	17	None	-16218	6	Human	4.2	pEC50	=	4.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	443	6	6	12	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	1713	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	1713	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12213051
	1713	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12761346
	5957	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	5957	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12213051
	5957	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12761346
	91	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	91	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12213051
	91	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12761346
	CHEMBL14249	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	CHEMBL14249	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12213051
	CHEMBL14249	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12761346
	DB00171	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	DB00171	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12213051
	DB00171	520	68	None	-165	10	Human	4.9	pEC50	=	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	507	8	7	14	-1.6	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	12761346
	1714	521	0	None	-158	3	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	519	8	3	18	-4.0	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)([O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	44123300	521	0	None	-158	3	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	519	8	3	18	-4.0	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=S)([O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N	10578132
	1734	3966	50	None	-1	7	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	12761346
	3639	3966	50	None	-1	7	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	12761346
	6133	3966	50	None	-1	7	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	12761346
	CHEMBL336296	3966	50	None	-1	7	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	12761346
	DB04005	3966	50	None	-1	7	Human	5.2	pEC50	=	5.2	Functional	UnclassifiedUnclassified	Guide to Pharmacology	484	8	7	12	-2.5	O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	12761346
	136861374	2812	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1180	22	10	13	8.1	[Na]OP(=O)(Cc1cc(ccc1NC(=O)c1ccc(c(c1)NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(cc1CP(=O)(O[Na])O)CP(=O)(O[Na])O)C)CP(=O)(O[Na])O)O	19815812
	4046	2812	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1180	22	10	13	8.1	[Na]OP(=O)(Cc1cc(ccc1NC(=O)c1ccc(c(c1)NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(cc1CP(=O)(O[Na])O)CP(=O)(O[Na])O)C)CP(=O)(O[Na])O)O	19815812
	73755075	2812	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1180	22	10	13	8.1	[Na]OP(=O)(Cc1cc(ccc1NC(=O)c1ccc(c(c1)NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(cc1CP(=O)(O[Na])O)CP(=O)(O[Na])O)C)CP(=O)(O[Na])O)O	19815812
	90488895	2812	0	None	-	1	Human	6.3	pEC50	=	6.3	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1180	22	10	13	8.1	[Na]OP(=O)(Cc1cc(ccc1NC(=O)c1ccc(c(c1)NC(=O)c1cccc(c1)NC(=O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(cc1CP(=O)(O[Na])O)CP(=O)(O[Na])O)C)CP(=O)(O[Na])O)O	19815812
	1762	2811	0	None	-	1	Human	7.5	pEC50	=	7.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	986	14	4	15	3.9	[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]	18404494
	73755007	2811	0	None	-	1	Human	7.5	pEC50	=	7.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	986	14	4	15	3.9	[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]	18404494
	90488883	2811	0	None	-	1	Human	7.5	pEC50	=	7.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	986	14	4	15	3.9	[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]	18404494
	1756	463	10	None	-38	2	Human	8.5	pEC50	=	8.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	10578132
	1756	463	10	None	-38	2	Human	8.5	pEC50	=	8.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	15893764
	5310954	463	10	None	-38	2	Human	8.5	pEC50	=	8.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	10578132
	5310954	463	10	None	-38	2	Human	8.5	pEC50	=	8.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	15893764
	CHEMBL336292	463	10	None	-38	2	Human	8.5	pEC50	=	8.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	10578132
	CHEMBL336292	463	10	None	-38	2	Human	8.5	pEC50	=	8.5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	647	11	7	14	1.1	CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O	15893764
	1711	77	15	None	-64565	7	Human	4.0	pEC50	None	4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	553	9	7	15	-0.9	CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10578132
	5310983	77	15	None	-64565	7	Human	4.0	pEC50	None	4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	553	9	7	15	-0.9	CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10578132
	CHEMBL336208	77	15	None	-64565	7	Human	4.0	pEC50	None	4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	553	9	7	15	-0.9	CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10578132
	15993	1327	51	None	1	2	Human	4.9	pEC50	None	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10578132
	1760	1327	51	None	1	2	Human	4.9	pEC50	None	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10578132
	CHEMBL335538	1327	51	None	1	2	Human	4.9	pEC50	None	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10578132
	DB03222	1327	51	None	1	2	Human	4.9	pEC50	None	4.9	Functional	UnclassifiedUnclassified	Guide to Pharmacology	491	8	6	13	-0.6	O[C@H]1C[C@@H](O[C@@H]1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cnc2c1ncnc2N	10578132
	115205	760	0	None	-	1	Human	5.1	pEC50	None	5.1	Functional	UnclassifiedUnclassified	Guide to Pharmacology	715	12	6	16	1.5	O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10578132
	1757	760	0	None	-	1	Human	5.1	pEC50	None	5.1	Functional	UnclassifiedUnclassified	Guide to Pharmacology	715	12	6	16	1.5	O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10578132
	CHEMBL2407634	760	0	None	-	1	Human	5.1	pEC50	None	5.1	Functional	UnclassifiedUnclassified	Guide to Pharmacology	715	12	6	16	1.5	O[C@@H]1[C@H](OC(=O)c2ccc(cc2)C(=O)c2ccccc2)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(OP(=O)(OP(=O)(O)O)O)O	10578132
	135973538	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	1728	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	2966	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	4261196	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	5361	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	CHEMBL265502	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	DB04786	3710	33	None	-2	10	Human	8.2	pIC50	=	8.2	Functional	NoneNone	Drug Central	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	None
	136677322	3296	24	None	-398	9	Human	5.0	pIC50	=	5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	773	9	7	15	3.9	OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1	10578132
	1739	3296	24	None	-398	9	Human	5.0	pIC50	=	5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	773	9	7	15	3.9	OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1	10578132
	656725	3296	24	None	-398	9	Human	5.0	pIC50	=	5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	773	9	7	15	3.9	OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1	10578132
	CHEMBL1160031	3296	24	None	-398	9	Human	5.0	pIC50	=	5	Functional	UnclassifiedUnclassified	Guide to Pharmacology	773	9	7	15	3.9	OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1	10578132
	135973538	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	1728	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	2966	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	4261196	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	5361	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	CHEMBL265502	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	DB04786	3710	33	None	-2	10	Human	5.4	pIC50	=	5.4	Functional	UnclassifiedUnclassified	Guide to Pharmacology	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10578132
	1762	2811	0	None	-	1	Human	6.8	pIC50	=	6.8	Functional	UnclassifiedUnclassified	Guide to Pharmacology	986	14	4	15	3.9	[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]	19815812
	73755007	2811	0	None	-	1	Human	6.8	pIC50	=	6.8	Functional	UnclassifiedUnclassified	Guide to Pharmacology	986	14	4	15	3.9	[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]	19815812
	90488883	2811	0	None	-	1	Human	6.8	pIC50	=	6.8	Functional	UnclassifiedUnclassified	Guide to Pharmacology	986	14	4	15	3.9	[Na]OS(=O)(=O)c1cc(NC(=O)c2ccc(c(c2)NC(=O)Nc2cc(ccc2C)C(=O)Nc2cc(cc3c2cc(cc3)S(=O)(=O)O[Na])S(=O)(=O)O[Na])C)c2c(c1)ccc(c2)S(=O)(=O)O[Na]	19815812

Get vendors

Ligands (move mouse cursor over ligand name to see structure)					Receptor			Assay information							Chemical information
Sel. page	Similar- ity	Common name	GPCRdb ID	#Vendors	Reference ligand	Fold selectivity	# Tested GPCRs	Species	p-value (-log)	Activity Type	Activity Relation	Activity Value	Assay Type	Assay Description	Source	Mol weight	Rot Bonds	H don	H acc	LogP	Smiles	DOI
		11636757	2810	4	None	-	1	Human	6.3	pIC50	=	6.3	Binding	Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		136776947	2810	4	None	-	1	Human	6.3	pIC50	=	6.3	Binding	Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		1761	2810	4	None	-	1	Human	6.3	pIC50	=	6.3	Binding	Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		CHEMBL1207514	2810	4	None	-	1	Human	6.3	pIC50	=	6.3	Binding	Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)Inhibitory concentration against P2Y11 receptor expressed in 1321N1 astrocytoma Cells; (n=7)	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		136825091	14962	2	None	-	1	Human	6.0	pKi	=	6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1324	18	12	17	7.3	CCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3CC)c2)c1	10.1021/jm050301p
		451869	14962	2	None	-	1	Human	6.0	pKi	=	6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1324	18	12	17	7.3	CCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3CC)c2)c1	10.1021/jm050301p
		CHEMBL1208520	14962	2	None	-	1	Human	6.0	pKi	=	6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1324	18	12	17	7.3	CCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3CC)c2)c1	10.1021/jm050301p
		CHEMBL276295	14962	2	None	-	1	Human	6.0	pKi	=	6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1324	18	12	17	7.3	CCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3CC)c2)c1	10.1021/jm050301p
		11564437	14864	0	None	-	1	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1336	16	12	17	7.4	O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2Cl)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2Cl)c1	10.1021/jm050301p
		CHEMBL1207516	14864	0	None	-	1	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1336	16	12	17	7.4	O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2Cl)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2Cl)c1	10.1021/jm050301p
		CHEMBL413180	14864	0	None	-	1	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1336	16	12	17	7.4	O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2Cl)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2Cl)c1	10.1021/jm050301p
		135973538	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		1728	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		2966	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		4261196	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		5361	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		CHEMBL265502	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		DB04786	3710	33	None	-1	2	Human	7.0	pKi	=	7.0	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		CHEMBL5289838	194664	0	None	-	1	Human	7.8	pKi	=	7.8	Binding	Antagonist activity at P2Y11 (unknown origin)Antagonist activity at P2Y11 (unknown origin)	ChEMBL	906	10	16	7	6.0	Cc1ccc(C(=O)Nc2cc([SH](=O)(O)O)cc3ccc([SH](=O)(O)O)cc23)cc1NC(=O)Nc1cc(C(=O)Nc2cc([SH](=O)(O)O)cc3ccc([SH](=O)(O)O)cc23)ccc1C	10.1021/acs.jmedchem.5b01972
		CHEMBL5316131	194664	0	None	-	1	Human	7.8	pKi	=	7.8	Binding	Antagonist activity at P2Y11 (unknown origin)Antagonist activity at P2Y11 (unknown origin)	ChEMBL	906	10	16	7	6.0	Cc1ccc(C(=O)Nc2cc([SH](=O)(O)O)cc3ccc([SH](=O)(O)O)cc23)cc1NC(=O)Nc1cc(C(=O)Nc2cc([SH](=O)(O)O)cc3ccc([SH](=O)(O)O)cc23)ccc1C	10.1021/acs.jmedchem.5b01972
		11679781	14861	0	None	-	1	Human	5.6	pKi	=	5.6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=4Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=4	ChEMBL	1356	20	12	19	6.4	COCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3COC)c2)c1	10.1021/jm050301p
		CHEMBL1207473	14861	0	None	-	1	Human	5.6	pKi	=	5.6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=4Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=4	ChEMBL	1356	20	12	19	6.4	COCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3COC)c2)c1	10.1021/jm050301p
		CHEMBL409304	14861	0	None	-	1	Human	5.6	pKi	=	5.6	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=4Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=4	ChEMBL	1356	20	12	19	6.4	COCc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3COC)c2)c1	10.1021/jm050301p
		16163320	14746	0	None	-	1	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1420	18	12	17	9.5	O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2-c2ccccc2)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2-c2ccccc2)c1	10.1021/jm050301p
		CHEMBL1206368	14746	0	None	-	1	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1420	18	12	17	9.5	O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2-c2ccccc2)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2-c2ccccc2)c1	10.1021/jm050301p
		CHEMBL266646	14746	0	None	-	1	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1420	18	12	17	9.5	O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2-c2ccccc2)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)O)c4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)ccc2-c2ccccc2)c1	10.1021/jm050301p
		135973538	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		1728	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		2966	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		4261196	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		5361	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		CHEMBL265502	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		DB04786	3710	33	None	-1	2	Human	6.5	pKi	=	6.5	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=6	ChEMBL	1296	16	12	17	6.7	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		11636757	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		136776947	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		1761	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		CHEMBL1207514	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	10.1021/jm050301p
		10080219	14855	0	None	-	1	Human	6.4	pKi	=	6.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1352	18	12	17	8.4	CC(C)c1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C(C)C)c2)c1	10.1021/jm050301p
		136825093	14855	0	None	-	1	Human	6.4	pKi	=	6.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1352	18	12	17	8.4	CC(C)c1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C(C)C)c2)c1	10.1021/jm050301p
		CHEMBL1207434	14855	0	None	-	1	Human	6.4	pKi	=	6.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1352	18	12	17	8.4	CC(C)c1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C(C)C)c2)c1	10.1021/jm050301p
		CHEMBL405500	14855	0	None	-	1	Human	6.4	pKi	=	6.4	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1352	18	12	17	8.4	CC(C)c1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C(C)C)c2)c1	10.1021/jm050301p
		16155350	14865	0	None	-	1	Human	7.1	pKi	=	7.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1328	18	12	19	6.1	COc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3OC)c2)c1	10.1021/jm050301p
		CHEMBL1207525	14865	0	None	-	1	Human	7.1	pKi	=	7.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1328	18	12	19	6.1	COc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3OC)c2)c1	10.1021/jm050301p
		CHEMBL413910	14865	0	None	-	1	Human	7.1	pKi	=	7.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=7	ChEMBL	1328	18	12	19	6.1	COc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3OC)c2)c1	10.1021/jm050301p
		136880426	14863	4	None	-	1	Human	5.1	pKi	=	5.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1058	12	10	15	4.2	Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)ccc1C	10.1021/jm050301p
		369605	14863	4	None	-	1	Human	5.1	pKi	=	5.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1058	12	10	15	4.2	Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)ccc1C	10.1021/jm050301p
		CHEMBL1207502	14863	4	None	-	1	Human	5.1	pKi	=	5.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1058	12	10	15	4.2	Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)ccc1C	10.1021/jm050301p
		CHEMBL411554	14863	4	None	-	1	Human	5.1	pKi	=	5.1	Binding	Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3Inhibitory concentration against P2Y purinoceptor 11 expressed in 1321N1 astrocytoma cells; n=3	ChEMBL	1058	12	10	15	4.2	Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)ccc1C	10.1021/jm050301p
		11636757	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	UnclassifiedUnclassified	Guide to Pharmacology	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	16250663
		136776947	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	UnclassifiedUnclassified	Guide to Pharmacology	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	16250663
		1761	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	UnclassifiedUnclassified	Guide to Pharmacology	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	16250663
		CHEMBL1207514	2810	4	None	-	1	Human	7.4	pKi	=	7.4	Binding	UnclassifiedUnclassified	Guide to Pharmacology	1304	16	12	17	6.4	O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1F)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O	16250663

Join us

Cite us

Main reference

Ligand source activities (1 row/activity)